Arrevus
Conquering antibiotic resistance by targeting critical diseases with innovative DPCs.
est. 2015
Qpex Biopharma
Focusing on Resistance in Antibiotic Development
29 employees · est. 2018 · San Diego, United States
Arrevus is the older company (2015 vs 2018).
Side-by-Side Comparison
| Metric | Arrevus | Qpex Biopharma |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2018 |
| Headquarters | ||
| Headquarters | Not tracked yet | San Diego, United States |
| Employees | ||
| Employees | Not tracked yet | 29 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Grant | Grant |
| Total Funding | ||
| Total Funding | $2.05M | $63.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Antibiotic Resistance, DPCs, Drug Development, Clinical Implications, Bacterial Resistance, MRSA, Antimicrobial Peptides, Life-threatening Diseases, Patient Outcomes, Innovative Therapies, Pharmaceutical Research, Biomedical Innovation | Antimicrobial Resistance, Infectious Diseases, Drug Development, Antibiotics, Biopharmaceuticals, Antibiotic Resistance, San Diego, Public-Private Partnerships, Innovation In Antibiotic Development, Regulatory Approvals, Anti-Infective Therapies, Drug Discovery, Microbiology, Boron Chemistry |
| Website | ||
| Website | arrevus.com | qpexbio.com |
About Arrevus
Arrevus is a biotechnology and pharmaceutical startup, founded in 2015, with a mission to address antibiotic resistance in critical diseases. The company's focus lies in developing Designer Proline-rich Antimicrobial Peptide Chaperone Protein Inhibitors (DPCs) for diseases where antibiotic resistanc...
About Qpex Biopharma
Qpex Biopharma is a biotechnology company based in the United States, founded in 2018 and acquired by Shionogi, Inc in July 2023. The company's slogan "Focusing on Resistance in Antibiotic Development" reflects its mission to address drug resistance in infectious diseases. Qpex has a remarkable trac...
We will tell you when either one moves
BounceWatch watches Arrevus and Qpex Biopharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Arrevus and Qpex Biopharma — by email.
Frequently Asked Questions
Compare Arrevus with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Arrevus on 12 Sep 2024, and Qpex Biopharma on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.